Cargando…
The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo
BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. P...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546900/ https://www.ncbi.nlm.nih.gov/pubmed/37795429 http://dx.doi.org/10.4102/sajhivmed.v24i1.1495 |
_version_ | 1785114954312974336 |
---|---|
author | Lebina, Limakatso Malatji, Tumiso Nabeemeeah, Firdaus Motsomi, Kegaugetswe Siwelana, Tsundzukani Hlongwane, Khuthadzo Martinson, Neil |
author_facet | Lebina, Limakatso Malatji, Tumiso Nabeemeeah, Firdaus Motsomi, Kegaugetswe Siwelana, Tsundzukani Hlongwane, Khuthadzo Martinson, Neil |
author_sort | Lebina, Limakatso |
collection | PubMed |
description | BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. Patients were enrolled if they were ≥ 40 years, HIV-positive, and virologically suppressed on ART. Data were analysed descriptively, and a binomial regression model was used to identify risk factors for NCDs. RESULTS: The majority of participants (65%; 319/488) were women. Most (83%; 405/488) were aged 40–59 years; 60% (285/472) were overweight or obese. Based on self-report, 22% (107/488) were currently smokers. Almost half (44%) 213/488) reported daily consumption of vegetables and 65% (319/488) exercised regularly and 39% (190/488) reported treatment for another chronic disease. The leading comorbid conditions were hypertension (32%; 158/488) and diabetes mellitus (5%; 24/488). Risk factors for hypertension included age 60 years and older (relative risk [RR]: 1.72; 95% confidence interval [CI]: 1.29–2.30) diabetes (RR: 1.42; 95% CI: 1.08–1.87), overweight (RR: 1.32; 95% CI: 1.03–1.69) and obesity (RR: 1.69; 95% CI: 1.32–2.17). CONCLUSION: There is a high prevalence, both of risk factors for NCDs and multimorbidity (> 1 chronic disease) in patients who are ≥ 40 years and virologically suppressed on ART. |
format | Online Article Text |
id | pubmed-10546900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AOSIS |
record_format | MEDLINE/PubMed |
spelling | pubmed-105469002023-10-04 The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo Lebina, Limakatso Malatji, Tumiso Nabeemeeah, Firdaus Motsomi, Kegaugetswe Siwelana, Tsundzukani Hlongwane, Khuthadzo Martinson, Neil South Afr J HIV Med Original Research BACKGROUND: Non-communicable diseases (NCDs) are an emerging global public health problem. OBJECTIVES: To assess the prevalence of NCDs and their risk factors among adults on antiretroviral therapy (ART). METHOD: This was a cross-sectional study (July 2019 – January 2020) in Limpopo, South Africa. Patients were enrolled if they were ≥ 40 years, HIV-positive, and virologically suppressed on ART. Data were analysed descriptively, and a binomial regression model was used to identify risk factors for NCDs. RESULTS: The majority of participants (65%; 319/488) were women. Most (83%; 405/488) were aged 40–59 years; 60% (285/472) were overweight or obese. Based on self-report, 22% (107/488) were currently smokers. Almost half (44%) 213/488) reported daily consumption of vegetables and 65% (319/488) exercised regularly and 39% (190/488) reported treatment for another chronic disease. The leading comorbid conditions were hypertension (32%; 158/488) and diabetes mellitus (5%; 24/488). Risk factors for hypertension included age 60 years and older (relative risk [RR]: 1.72; 95% confidence interval [CI]: 1.29–2.30) diabetes (RR: 1.42; 95% CI: 1.08–1.87), overweight (RR: 1.32; 95% CI: 1.03–1.69) and obesity (RR: 1.69; 95% CI: 1.32–2.17). CONCLUSION: There is a high prevalence, both of risk factors for NCDs and multimorbidity (> 1 chronic disease) in patients who are ≥ 40 years and virologically suppressed on ART. AOSIS 2023-09-18 /pmc/articles/PMC10546900/ /pubmed/37795429 http://dx.doi.org/10.4102/sajhivmed.v24i1.1495 Text en © 2023. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
spellingShingle | Original Research Lebina, Limakatso Malatji, Tumiso Nabeemeeah, Firdaus Motsomi, Kegaugetswe Siwelana, Tsundzukani Hlongwane, Khuthadzo Martinson, Neil The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title | The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title_full | The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title_fullStr | The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title_full_unstemmed | The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title_short | The prevalence of multimorbidity in virally suppressed HIV-positive patients in Limpopo |
title_sort | prevalence of multimorbidity in virally suppressed hiv-positive patients in limpopo |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546900/ https://www.ncbi.nlm.nih.gov/pubmed/37795429 http://dx.doi.org/10.4102/sajhivmed.v24i1.1495 |
work_keys_str_mv | AT lebinalimakatso theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT malatjitumiso theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT nabeemeeahfirdaus theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT motsomikegaugetswe theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT siwelanatsundzukani theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT hlongwanekhuthadzo theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT martinsonneil theprevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT lebinalimakatso prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT malatjitumiso prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT nabeemeeahfirdaus prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT motsomikegaugetswe prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT siwelanatsundzukani prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT hlongwanekhuthadzo prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo AT martinsonneil prevalenceofmultimorbidityinvirallysuppressedhivpositivepatientsinlimpopo |